Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2476 to 2490 of 7683 results

  1. Artificial intelligence technologies to help detect fractures on X-rays in urgent care

    In development [GID-HTE10044] Expected publication date: 14 January 2025

    Health technology evaluations
    In development

  2. Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids in people aged 12 and over [ID6377]

    In development [GID-TA11512] Expected publication date: 29 January 2025

    Technology appraisal guidance
    In development

  3. Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitable ID3981

    In development [GID-TA10912] Expected publication date: 18 June 2025

    Technology appraisal guidance
    In development

  4. Urinary Tract Infection (recurrent): antimicrobial prescribing

    In development [GID-NG10422] Expected publication date: 12 December 2024

    NICE guideline
    In development

  5. Dapagliflozin for treating chronic kidney disease [ID6411]

    In development [GID-TA11547] Expected publication date: TBC

    Technology appraisal guidance
    In development

  6. Talquetamab for treating relapsed or refractory multiple myeloma after 3 treatments ID5082

    In development [GID-TA10969] Expected publication date: TBC

    Technology appraisal guidance
    In development

  7. PillCam COLON 2 for investigation of the colon through direct visualisation

    In development [GID-DG10083] Expected publication date: 17 July 2025

    Diagnostics guidance
    In development

  8. Anhydrous sodium thiosulfate (Pedmarqsi) for preventing ototoxicity caused by cisplatin chemotherapy in people aged 1 month to 17 years with localised solid tumours [ID1001]

    In development [GID-TA10611] Expected publication date: 18 December 2024

    Technology appraisal guidance
    In development

  9. Olipudase alfa for treating Niemann-Pick disease types A and B [ID3913 ]

    In development [GID-HST10060] Expected publication date: TBC

    Highly specialised technologies guidance
    In development

  10. Fosdenopterin for treating molybdenum cofactor deficiency type A [ID6264]

    In development [GID-HST10055] Expected publication date: 29 January 2025

    Highly specialised technologies guidance
    In development

  11. Pneumonia QS update: topic engagement

    We are listening to your views on this Quality standard. Comments close 21 November 2024.

    Quality standard
    In consultation

  12. Advanced breast cancer: diagnosis and management (Partial update)

    In development [GID-NG10430] Expected publication date: TBC

    NICE guideline
    In development

  13. Pneumonia QS update

    In development [GID-QS10190] Expected publication date: 14 August 2025

    Quality standard
    In development

  14. Belantamab mafodotin for treating relapsed or refractory multiple myeloma after 2 therapies [ID5108]

    Awaiting development [GID-TA11018] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Advanced breast cancer: diagnosis and management (Partial update): draft scope consultation

    We are listening to your views on this NICE guideline. Comments close 21 November 2024.

    NICE guideline
    In consultation